Popular Articles
Burdock Root

Physicians To Make Denton House Call On Health System Reform
What
generic viagra online
HIV Infection And Chronic Drinking Have A Synergistic, Damaging Effect On The Brain
More than half of clinic patients infected with the human immunodeficiency virus (HIV) report they also drink heavily. While highly active antiretroviral therapy has helped to reduce HIV-related cognitive and motor deficits, neuropsychological deficits may continue and even be exacerbated by alcohol. A study of memory deficits has found that HIV infection and chronic alcoholism have synergistic, damaging effects on brain function.
News of the day
Mayo Clinic Study Continues To Refine Most Effective Methods To Predict Alzheimer's Disease
A new Mayo Clinic study found that the clinical criteria for mild cognitive impairment is better at predicting who will develop Alzheimer"s disease than a single memory test. This is one more piece of information to aid in the identification and early treatment of individuals most likely to develop Alzheimer"s disease. This study will be presented at the Alzheimer"s Association International Conference on Alzheimer"s Disease on July 14 in Vienna.
Sexual Health

New Stem Cell Research Unlocks Unknown Therapies

"Stem cell research and regenerative medicine are in an extremely exciting phase right now. We are gaining knowledge very fast and many companies are being formed and are starting clinical trials in different areas," says Dr Jonas Frisçİn. As an example, a first-in-human study was just initiated for Parkinson"s disease patients with the drug product, sNN0031, from the Swedish company NeuroNova. The drug, which is administered into the fluid-filled cavities of the brain, has shown long lasting recovery and formation of new cells in animal models of Parkinson"s disease. Last year, a treatment for ALS entered the clinical trial phase. Disorders in the brain and nervous system result in more hospitalizations than any other disease group, and treatments entail large costs to society. The research field of neuroscience is one of Sweden"s finest. This had resulted in achievements within numerous areas of basic science with considerable scope to direct clinical applications. These include research advances concerning the origin and repair of nerve cell damage following stroke and spinal cord injury, as well as research into major degenerative diseases such as Parkinson"s and Alzheimer"s. Dr Frisçİn is one of Sweden"s leading stem cell researchers, since many years with a focus on nerve stem cells. Among his most recent publications is an article in Science, April 3rd, 2009 where evidence is shown for renewal of heart muscle cells in humans, a result that can be used to develop therapeutic strategies for cardiac pathologies. NeuroNova AB is a Swedish biopharmaceutical company working with neurogenesis and neuroprotection for treatment of several currently incurable neurodegenerative diseases. Dr Jonas Frisçİn is the scientific founder of NeuroNova. Sabina Bossi Karolinska Institutet


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):